ORX:STO
Orexo AB
1,01 SEK
0,00%
(0,00) 1D
18-ноя., 17:29:44 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Mkt. cap
352,99 млн
Avg. vol.
771,26 миң
Volume
0,00
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
Mkt. cap
352,99 млн
Avg. vol.
771,26 миң
Volume
0,00
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
TradingView
·
1 саат мурун
Stock Market: Will S&P 500 Open Up or Down Today?
Chattanooga Times Free Press
·
1 саат мурун
A fifth straight drop for the S&P 500 drags Wall Street to its longest losing streak since June
BigGo Finance
·
2 саат мурун
UBS Sets S&P 500 Target of 8,200 by End-2027, Implying Roughly 12% Upside, But Cuts Rating to Neutral
FOREX.com
·
2 саат мурун
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com